moneyheap
VTR · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is Ventas, Inc. (VTR) stock moving?
Ventas reported Q3 2026 results on Oct 27 (8-K Item 2.02), and the stock fell from $87.42 to $83.34 that day on volume of 5.4M, then dropped to a $76.75 low on Oct 28 on 6.2M shares before closing at $81.07. Since then the stock has recovered steadily to a $90.34 close on Nov 10, its highest close in the 30-day window and about 11% above the Oct 28 close. Volume has eased from the post-earnings peak, and the Nov 10 session traded only 2.3M shares, which tempers the strength of the move. Analyst actions were mixed: BNP Paribas cut its target from $110 to $93, Cantor Fitzgerald kept an Overweight rating while lowering its target to $95, and Jefferies raised its target to $98 from $95 on Nov 2. The $500M 5.5% notes due 2033, priced at 99.441% of principal on Nov 6 and issued on Nov 10 under the existing shelf, are a routine refinancing for general corporate purposes and do not change the outlook. Against the current price, the Jefferies target implies limited remaining upside, and the lower targets from other brokers show that expectations were reset after the report.
News behind the analysis
- Ventas Prices $500 Million Senior Notes OfferingVentas announced pricing of a $500 million underwritten public offering of 5.5% senior notes due 2033.
- Reported Earlier, Ventas Prices $500M Of 5.500% Senior Notes Due 2033 At 99.441% Of Principal Amount In Underwritten Public OfferingThe 5.500% notes due 2033 were priced at 99.441% of principal amount in the underwritten public offering.
- Jefferies Adjusts Price Target on Ventas to $98 From $95Jefferies raised its price target on Ventas from $95 to $98.
- Cantor Fitzgerald Maintains Overweight on Ventas, Lowers Price Target to $95Cantor Fitzgerald kept its Overweight rating on Ventas but lowered its price target to $95 after third-quarter results.
- BNP Paribas Adjusts Price Target on Ventas to $93 From $110BNP Paribas cut its price target on Ventas from $110 to $93 following the third-quarter report.
- Ventas Q3 2026 Earnings Call TranscriptVentas reported third-quarter 2026 financial results on Oct 27 and held its earnings call, with the transcript published Oct 28.
About Ventas, Inc.
Ventas is a large Chicago-based real estate investment trust (REIT) that owns senior housing communities, outpatient medical buildings, research labs and other healthcare properties, with a market value of roughly $43–45 billion. What sets it apart is its growing bet on senior housing that it runs through operators and shares in the profits. This part of the business was expected to make up about 60% of the company by the end of 2026.
How it makes money
Ventas makes most of its money in two ways. First, it earns the operating income from senior housing communities that it owns and that hired managers run for it. Its own name for this segment is SHOP (senior housing operating portfolio), and it is the largest and fastest-growing part of the business. Second, it collects rent from tenants on long-term leases: outpatient medical offices, research buildings, and properties leased to operators under triple-net leases, where the tenant pays most of the property costs. Yearly revenue is roughly $7 billion. As a REIT, it must pay out most of its taxable income as dividends, and its profits are usually measured by normalized FFO (funds from operations) rather than net income.
What usually moves VTR
- Occupancy and rent rates in senior housing
- Interest rates and borrowing costs
- Aging US population and the limited number of new senior housing buildings
- Pace and pricing of acquisitions
- Labor and operating costs at the communities